COVID-19 associated coagulopathy and thrombosis in cancer
Research article
[키워드] adverse outcome
amplify
anti-cancer treatment
Antithrombotic
Cancer
cancer patient
caused
clinical study
clinically
Coagulation
Coagulopathy
Combination
COVID-19
COVID-19 infection
COVID-19 vaccination
D-dimer
disease
Disseminated intravascular coagulation
effective
Efficacy and safety
evaluated
haematological malignancy
hypercoagulable
immune response
Immune suppression
IMPROVE
incidence
Infection
intensity
lung cancer
management
outcome
Patient
patients
Prophylaxis
Pulmonary embolism
risk
Safe
SARS-CoV-2
selected
seroconversion rate
Severe COVID-19 Infection
Specific
thromboembolic complications
thrombosis
thrombotic microangiopathy
vaccination
venous thromboembolic
[DOI] 10.1016/j.thromres.2021.12.006 [Article Type] Research article
[DOI] 10.1016/j.thromres.2021.12.006 [Article Type] Research article